FMP

FMP

Enter

NERV - Minerva Neuroscience...

Corporate Actions of Minerva Neurosciences, Inc.(NERV), Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development

photo-url-https://financialmodelingprep.com/image-stock/NERV.png

Minerva Neurosciences, Inc.

NERV

NASDAQ

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

3.33 USD

0.04 (1.2%)

Earnings

We are unable to load the chart at this time.

fmp-logo

Dividends

We are unable to load the chart at this time.

fmp-logo

Splits

We are unable to load the chart at this time.

fmp-logo

From:

To:

Date

Revenue

Earnings

Estimated Earnings

Surprise

No data found!

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep